{"id":"W3095664938","doi":"10.1182/blood-2020-135818","title":"Subcutaneous Mosunetuzumab in Relapsed or Refractory B-Cell Lymphoma: Promising Safety and Encouraging Efficacy in Dose Escalation Cohorts","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Jewish General Hospital","funders":"","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001101996,0.0006542646,0.0009437581,0.0003522997,0.0003092634,0.0007461626,0.0004558881,0.0003776786,0.001653998],"category_scores_gemma":[0.0006754713,0.0002047592,0.0006273662,0.0003374649,0.0002810892,0.0005473697,0.0003415664,0.001881414,0.0007436504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007058851,"about_ca_system_score_gemma":0.0005037092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006576916,"about_ca_topic_score_gemma":0.001886096,"domain_scores_codex":[0.9996932,0.0001047381,0.00002517439,0.00006113991,0.00005741476,0.00005842312],"domain_scores_gemma":[0.9996112,0.00005668669,0.0000741281,0.00006941181,0.00003058548,0.0001579618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.07970313,0.03175187,0.01870958,0.0005485127,0.001072172,0.0005297353,0.0005767787,0.005684933,0.1567794,0.0004237077,0.01019232,0.6940279],"study_design_scores_gemma":[0.1608315,0.5726492,0.1619947,0.0002588497,0.001410965,0.002902819,0.000254275,0.01564316,0.05249991,0.001857214,0.02957551,0.0001219876],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905641,0.003142666,0.002068921,0.0003771257,0.00004400831,0.0008478955,0.000658678,0.0002603424,0.002036122],"genre_scores_gemma":[0.9924166,0.001505308,0.002615438,0.0004053519,0.00005113747,0.0005946551,0.001341258,0.00004533074,0.001024868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001653998,"threshold_uncertainty_score":0.005828023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02187764696750958,"score_gpt":0.275153758085558,"score_spread":0.2532761111180484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}